On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Avant Diagnostics (AVDX): Trials and Tribulations

Recently, in Avant Diagnostics set to exploit new opportunities in the laboratory testing market (http://dtn.fm/hg8TK), we reported that ‘OvaDx is now undergoing 510K trials.’ It seems we jumped the gun. We reached out to Avant’s CEO, Gregg Linn, to get clarification on our report and he confirmed that the OvaDx approval process hasn’t reached the […]

Avant Diagnostics, Inc. (AVDX) Ovarian Cancer Early Detection Diagnostic Tech Bolstered Mightily By Amarantus Bioscience Merger

According to recent analysis out late last year from the world’s second largest publisher of premium market reports, MarketsandMarkets, the global market for biomarkers is on-track to grow at a CAGR of 13.58 percent through 2020, reaching upwards of $45.55 billion on the strength of increasing healthcare, as well as R&D spending. A key driver […]

GTX Corp. (GTXO) Engages Leading Full-Service Investment Management Firm in Support of 2016 Corporate Initiative Roadmap

In a recent news release, GTX Corp. (OTC: GTXO) announced its hiring of Maxim Group LLC, a leading full-service investment banking, securities and wealth management firm, to provide strategic advisory services for the company’s corporate initiatives in 2016. GTXO’s primary goals for the coming months include expanding its global distribution network in Latin America and […]

Nutra Pharma Corp. (NPHC) is fighting for Myasthenia Gravis Sufferers with its Orphan Drug Application for RPI-78M

Nutra Pharma Corp. (OTCQB: NPHC) hasn’t forgotten about the sufferers of myasthenia gravis (MG). The Coral Springs, Florida-based company announced in December 2015 that it had applied for Orphan Status from the Food and Drug Administration (FDA) for its RPI-78M treatment for MG. RPI-78M, described as modified a-cobra toxin in the FDA Orphan Drug database, […]

GTX Corporation’s (GTXO) GPS SmartSole Technology Highlighted in Friendship Circle Article

GTX Corporation’s (OTC: GTXO) GPS SmartSole was the focus of a recent article highlighting the latest innovations in wearable tracking devices. The piece, titled “GPS SmartSole Gives Peace of Mind to Parents of Wanderers,” introduces readers to the considerable benefits of the GPS SmartSole, an invisible wearable technology device intended for non-invasive tracking of individuals […]

Moxian, Inc. (MOXC) Announces Exclusive Development Partnership with Xinhua Media Affiliate

Earlier today, Moxian, Inc. (OTCQB: MOXC) announced that its subsidiary, Moxian Technologies (Beijing) Co. Ltd., has entered into an exclusive development partnership with Xinhua New Media Culture Communication Co. Ltd. Through this partnership, Moxian will serve as the exclusive seller of advertising space for Xinhua’s popular gaming platform, the Xinhua New Media App. Per the […]

 

From Our Blog

Longeveron Inc. (NASDAQ: LGVN) Discusses 2023 Progress and 2024 Plans in Corporate Update

March 28, 2024

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing regenerative medicine for life-threatening conditions with unmet medical needs, recently released its full-year results for the period ended December 31, 2023, and provided a corporate update (https://ibn.fm/iORBu). Results from multiple studies using Longeveron’s lead investigational therapeutic candidate, Lomecel-B(TM), were announced by the company last year. “In 2023 […]

Rotate your device 90° to view site.